A new study identifies Florida spot keratopathy (FSK) as a stable, benign eye condition in pets and suggests a possible link ...

Patients with varying stages of glaucoma saw no significant difference in outcomes between standard and enhanced monofocal ...

ANI Pharmaceuticals offers an asymmetric opportunity in small-cap pharma, with a niche in generics, rare disease treatments, ...

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") today announced it received regulatory approval to ...

Reports Q3 revenue $9.02M, consensus $4.75M. “Roivant has broadened our clinical pipeline with the newly announced trial of brepocitinib in ...

The global veterinary eye care market size is estimated to grow by USD 1.05 billion from 2024-2028, according to Technavio.

Alumis Inc. will merge with a Southern California drug developer in a deal that extends the combined companies' cash into ...

Alumis is also developing another tyrosine kinase 2 blocker, A-005, for neuroinflammatory and neurodegenerative conditions ...

Ron Ofri, DVM, PhD, DECVO, provided veterinary professionals at the Veterinary Meeting & Expo conference ways to make ...

Tashi was referred to a specialist in Southern California who at the time was the only ophthalmologist in California, to ...